JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 114 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $27,121 | -67.3% | 14,660 | -58.8% | 0.00% | – |
| Q3 2022 | $83,000 | +22.1% | 35,599 | +58.2% | 0.00% | – |
| Q2 2022 | $68,000 | -59.0% | 22,500 | -8.2% | 0.00% | -100.0% |
| Q1 2022 | $166,000 | -19.0% | 24,500 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $205,000 | +12.6% | 24,500 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $182,000 | +9.0% | 24,500 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $167,000 | -24.4% | 24,500 | +14.0% | 0.00% | 0.0% |
| Q1 2021 | $221,000 | +176.2% | 21,500 | +87.0% | 0.00% | +100.0% |
| Q4 2020 | $80,000 | -19.2% | 11,500 | +4.5% | 0.00% | -50.0% |
| Q3 2020 | $99,000 | +35.6% | 11,000 | 0.0% | 0.00% | +100.0% |
| Q2 2020 | $73,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|